Nasdaq
USD
Rydex Biotechnology C (RYCFX)
55.29
-1.07
(-1.90%)
At close: 8:03:49 PM EST
Investment Information
- Min Initial Investment
- 2,500
- Min Initial Investment, IRA
- 10
- Min Initial Investment, AIP
- --
- Min Subsequent Investment
- 0
- Min Subsequent Investment, IRA
- --
- Min Subsequent Investment, AIP
- --
Broker Availability
- Mutual Of Omaha Investor Services Inc
- Cetera Advisors LLC
- Cetera Advisor Networks LLC
- UBS Financial Services Inc
- Protected Investors of America
- E TRADE Financial
- H&R Block Financial Advisors Inc
- American Trust Custody
- Morgan Stanley - Brokerage Accounts
- Pershing FundCenter
- Schwab Institutional
- Scottrade Load
- EP Fee Small
- Shareholders Services Group
- JPMorgan
- Merrill Lynch
- Vanguard
- T. Rowe Price
- TD Ameritrade Trust Company
- (Junk)CommonWealth PPS
- Fifth Third Securities, Inc.
- LPL SAM Eligible
- Nationwide Retirement Innovator
- Fidelity Retail FundsNetwork
- Fidelity Retail FundsNetwork-NTF
- Fidelity Institutional FundsNetwork
- Fidelity Institutional FundsNetwork-NTF
- DATALynx
- DATALynx NTF
- Ameriprise Brokerage
- Federated TrustConnect
- Federated TrustConnect NTF
- Cetera Advisors LLC- PAM, PRIME, Premier
- Cetera Advisor Networks LLC- PAM, PRIME, Premier
- Nationwide Retirement Resource
- RBC Wealth Management-Advisory Eligible
- Ameriprise SPS Advantage
- Mony Securities Corp
- CommonWealth NTF
- SunAmerica Securities Premier / Pinnacle
- Vanguard NTF
- ETrade No Load NTF
- ETrade No Load Fee
- ETrade Load Fee
- SunGard Transaction Network
- Royal Alliance
- Raymond James
- Raymond James WRAP Eligible
- Bear Stearns No-Load Transaction Fee
- Commonwealth Universe
- FTJ FundChoice
- Robert W. Baird & Co.
- DATALynx IMS
- HSBC Brokerage (USA) Inc
- JPMorgan INVEST
- WFA MF Advisory Updated 9.2.26
- RBC Wealth Management-Network Eligible
- DailyAccess Corporation RTC
- DailyAccess Corporation FRIAG
- WR Hambrecht Co LLC
- Sterne, Agee & Leach, Inc.,
- EP Fee Large
- JPMorgan INVEST NTF
- ING Financial Ptnrs PAM and PRIME Approv
- Ameritas NTFN
- Ameritas NTF P
- Firstrade
- Scottrade NTF
- Standard Retirement Services, Inc.
- TIAA-CREF Brokerage Services
- Thrivent – Advisory Eligible
- Pershing FundVest NTF
- Morgan Stanley Consulting Group Advisor
- Matrix Financial Solutions
- Trade PMR Transaction Fee
- Trade PMR NTF
- SB Pychx OFS A
- TD Ameritrade Retail
- TD Ameritrade Institutional
- ING Financial Advisers - SAS Funds
- Met Life Resources MFSP Alliance List
- ADP Access
- Mid Atlantic Capital Group
- HD Vest - Vest Advisor
- Securities America Advisors
- Bear Stearns
- Protected Investors of America NTF
- JP MORGAN NO-LOAD NTF
- JP MORGAN LOAD-WAIVED NTF
- JP MORGAN NTF
- JP MORGAN LOAD
- JP MORGAN NO-LOAD TRANSACTION FEE
- TD Ameritrade Retail NTF
- TD Ameritrade Institutional NTF
- Trust Company of America
- TIAA-CREF NTF
- MSWM Brokerage
- WFA Fdntl Choice/PIM Updated 9.2.26
- ADP Access Open Fund Architecture
- DailyAccess Corporation Mid-Atlantic
- RBC Wealth Management-Wrap Eligible
- Waddell & Reed Choice MAP Flex
- Investacorp NTF
- H Beck Inc.
- ING Financial Partners Inc.
- Securities America Inc.
- Vanguard Load
- Vanguard Load-Waived
- Zhejiang Akcome New Energy Technology Co Ltd
- Vanguard TF
- Morgan Stanley Portfolio Management
- JP Morgan No Load
- Smith Barney Portfolio Manager
- Merrill Edge
- DailyAccess Corporation Matrix
- DailyAccess Corporation MATC
- Cetera Financial Specialists LLC- Premier
- LPL SWM
- Schwab Advisor Services All Funds Available
- Schwab Advisor Services Mutual Fund OneSource & Other NTF Funds
- Lincoln Investment Planning
- Pershing Retirement Plan Network
- Ameriprise SPS Advisor
- HD Vest
- Kestra Financial
- Commonwealth (PPS Access Program)
- Commonwealth (NTF - PPS/Advisory)
- Commonwealth (PPS/Advisory)
- ADP Advisor Access Tier 2
- LPL Brokerage Availability
- Avantax
- Allowab (non-advisory)
- Mid Atlantic Clearing and Settlement
- Schwab (Non Transaction Fee)
- Schwab Advisor Services Funds for Transfer, Custody and Redemption Only
Fund Summary
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Fund Overview
| Category | Health |
| Fund Family | Rydex Funds |
| Net Assets | 131.59M |
| YTD Return | 25.85% |
| Yield | 0.00% |
| Morningstar Rating | |
| Inception Date | Sep 01, 2004 |
Performance & Risk
| YTD Return | 30.93% |
| 5y Average Return | 7.78% |
| Rank in Category (ytd) | 12 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 0.69 |
| Morningstar Risk Rating |
